Oxygen sensing in retinal health and disease

Ophthalmologica

Volumn 227, Issue 3, 2012, Pages 115-131

  Lange, Clemens A K ^a,b   Bainbridge, James W B ^a,c  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Oxygen sensing; Retina

Indexed keywords

HYPOXIA INDUCIBLE FACTOR; OXYGEN;

ANGIOGENESIS; BLOOD FLOW; HYPOXIA; NEUROPROTECTION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; OXYGEN SENSING; OXYGEN SUPPLY; RETINA; RETINA DEGENERATION; RETINA DISEASE; REVIEW; TISSUE OXYGENATION; VISUAL IMPAIRMENT;

ANIMALS; ELECTRON TRANSPORT; HUMANS; OXIDATIVE PHOSPHORYLATION; OXYGEN; OXYGEN CONSUMPTION; RETINA; RETINAL DISEASES;

EID: 84858994340     PISSN: 00303755     EISSN: 14230267     Source Type: Journal    
DOI: 10.1159/000331418     Document Type: Review

References (184)

1. Provis JM: Development of the primate retinal vasculature. Prog Retin Eye Res 2001; 20: 799-821. (Pubitemid 32918286)
2. Hickam JB, Sieker HO, Frayser R: Studies of retinal circulation and A-V oxygen difference in man. Trans Am Clin Climatol Assoc 1959; 71: 34-44.
3. Hickam JB, Frayser R: Aphotographic method for measuring the mean retinal circulation time using fluorescein. Invest Ophthalmol 1965; 4: 876-884.
4. Pournaras CJ, Rungger-Brandle E, Riva CE, Hardarson SH, Stefansson E: Regulation of retinal blood flow in health and disease. Prog Retin Eye Res 2008; 27: 284-330.
5. Hayreh SS: Physiological anatomy of the choroidal vascular bed. Int Ophthalmol 1983; 6: 85-93. (Pubitemid 13165002)
6. Alm A, Bill A: The oxygen supply to the retina. 2. Effects of high intraocular pressure and of increased arterial carbon dioxide tension on uveal and retinal blood flow in cats. A study with radioactively labelled microspheres including flow determinations in brain and some other tissues. Acta Physiol Scand 1972; 84: 306-319.
7. Bill A, Sperber GO: Control of retinal and choroidal blood flow. Eye (Lond) 1990; 4: 319-325. (Pubitemid 20307088)
8. Lutjen-Drecoll E: Choroidal innervation in primate eyes. Exp Eye Res 2006; 82: 357-361. (Pubitemid 43138948)
9. Pournaras CJ, Riva CE, Tsacopoulos M, Strommer K: Diffusion of O 2 in the retina of anesthetized miniature pigs in normoxia and hyperoxia. Exp Eye Res 1989; 49: 347-360. (Pubitemid 19239393)
10. Linsenmeier RA: Effects of light and darkness on oxygen distribution and consumption in the cat retina. J Gen Physiol 1986; 88: 521-542. (Pubitemid 17172465)
11. Yu DY, Cringle SJ, Alder VA, Su EN: Intraretinal oxygen distribution in rats as a function of systemic blood pressure. Am J Physiol 1994; 267:H2498-H2507.
12. Ahmed J, Braun RD, Dunn R Jr, Linsenmeier RA: Oxygen distribution in the macaque retina. Invest Ophthalmol Vis Sci 1993; 34: 516-521. (Pubitemid 23095204)
13. Haugh LM, Linsenmeier RA, Goldstick TK: Mathematical models of the spatial distribution of retinal oxygen tension and consumption, including changes upon illumination. Ann Biomed Eng 1990; 18: 19-36. (Pubitemid 20114413)
14. Kimble EA, Svoboda RA, Ostroy SE: Oxygen consumption and ATP changes of the vertebrate photoreceptor. Exp Eye Res 1980; 31: 271-288. (Pubitemid 11225419)
15. Wangsa-Wirawan ND, Linsenmeier RA: Retinal oxygen: fundamental and clinical aspects. Arch Ophthalmol 2003; 121: 547-557. (Pubitemid 36427642)
16. Linsenmeier RA, Braun RD: Oxygen distribution and consumption in the cat retina during normoxia and hypoxemia. J Gen Physiol 1992; 99: 177-197.
17. Alm A: Effects of norepinephrine, angiotensin, dihydroergotamine, papaverine, isoproterenol, histamine, nicotinic acid, and xanthinol nicotinate on retinal oxygen tension in cats. Acta Ophthalmol (Copenh) 1972; 50: 707-719.
18. Medrano CJ, Fox DA: Oxygen consumption in the rat outer and inner retina: light- and pharmacologically-induced inhibition. Exp Eye Res 1995; 61: 273-284.
19. Alder VA, Cringle SJ: Vitreal and retinal oxygenation. Graefes Arch Clin Exp Ophthalmol 1990; 228: 151-157. (Pubitemid 20095821)
20. Linsenmeier RA, Goldstick TK, Blum RS, Enroth-Cugell C: Estimation of retinal oxygen transients from measurements made in the vitreous humor. Exp Eye Res 1981; 32: 369-379. (Pubitemid 11096762)
21. Lange CA, Stavrakas P, Luhmann UF, de Silva DJ, Ali RR, Gregor ZJ, Bainbridge JW: Intraocular oxygen distribution in adVanced proliferative diabetic retinopathy. Am J Ophthalmol 2011, E-pub ahead of print.
22. Williamson TH, Grewal J, Gupta B, Mokete B, Lim M, Fry CH: Measurement of PO 2 during vitrectomy for central retinal vein occlusion, a pilot study. Graefes Arch Clin Exp Ophthalmol 2009; 247: 1019-1023.
23. Linsenmeier RA, Braun RD, McRipley MA, Padnick LB, Ahmed J, Hatchell DL, McLeod DS, Lutty GA: Retinal hypoxia in long-term diabetic cats. Invest Ophthalmol Vis Sci 1998; 39: 1647-1657. (Pubitemid 28361327)
24. Trick GL, Berkowitz BA: Retinal oxygenation response and retinopathy. Prog Retin Eye Res 2005; 24: 259-274. (Pubitemid 40018226)
25. de Gooyer TE, Stevenson KA, Humphries P, Simpson DA, Gardiner TA, Stitt AW: Retinopathy is reduced during experimental diabetes in a mouse model of outer retinal degeneration. Invest Ophthalmol Vis Sci 2006; 47: 5561-5568. (Pubitemid 46723810)
26. Holekamp NM, Shui YB, Beebe D: Lower intraocular oxygen tension in diabetic patients: possible contribution to decreased incidence of nuclear sclerotic cataract. Am J Ophthalmol 2006; 141: 1027-1032. (Pubitemid 43831034)
27. Drasdo N, Chiti Z, Owens DR, North RV: Effect of darkness on inner retinal hypoxia in diabetes. Lancet 2002; 359: 2251-2253. (Pubitemid 34717982)
28. Harris A, Arend O, Danis RP, EVans D, Wolf S, Martin BJ: Hyperoxia improves contrast sensitivity in early diabetic retinopathy. Br J Ophthalmol 1996; 80: 209-213. (Pubitemid 26090347)
29. Nguyen QD, Shah SM, Van AE, Sung JU, Vitale S, Campochiaro PA: Supplemental oxygen improves diabetic macular edema: a pilot study. Invest Ophthalmol Vis Sci 2004; 45: 617-624. (Pubitemid 38140522)
30. Pournaras CJ, Tsacopoulos M, Strommer K, Gilodi N, Leuenberger PM: Experimental retinal branch vein occlusion in miniature pigs induces local tissue hypoxia and vasoproliferative microangiopathy. Ophthalmology 1990; 97: 1321-1328. (Pubitemid 20353976)
31. Bardy M, Tsacopoulos M: Metabolic changes in the retina after experimental microembolism in the miniature pig (author's transl). Klin Monbl Augenheilkd 1978; 172: 451-460. (Pubitemid 9020080)
32. Stefansson E, Landers MB III, Wolbarsht ML: Increased retinal oxygen supply following pan-retinal photocoagulation and vitrectomy and lensectomy. Trans Am Ophthalmol Soc 1981; 79: 307-334.
33. Pournaras CJ, Ilic J, Gilodi N, Tsacopoulos M, Leuenberger MP: Experimental venous thrombosis: preretinal PO 2 before and after photocoagulation. Klin Monbl Augenheilkd 1985; 186: 500-501. (Pubitemid 15064872)
34. Donati G, Kapetanios A, Dubois-Dauphin M, Pournaras CJ: Caspase-related apoptosis in chronic ischaemic microangiopathy following experimental vein occlusion in minipigs. Acta Ophthalmol 2008; 86: 302-306. (Pubitemid 351785103)
35. Zhang Y, Fortune B, Atchaneeyasakul LO, McFarland T, Mose K, Wallace P, Main J, Wilson D, Appukuttan B, Stout JT: Natural history and histology in a rat model of laserinduced photothrombotic retinal vein occlusion. Curr Eye Res 2008; 33: 365-376. (Pubitemid 351507765)
36. Hardarson SH, Stefansson E: Oxygen saturation in central retinal vein occlusion. Am J Ophthalmol 2010; 150: 871-875.
37. Ding X, Patel M, Chan CC: Molecular pathology of age-related macular degeneration. Prog Retin Eye Res 2009; 28: 1-18.
38. Stefansson E, Geirsdottir A, Sigurdsson H: Metabolic physiology in age related macular degeneration. Prog Retin Eye Res 2011; 30: 72-80.
39. Metelitsina TI, Grunwald JE, DuPont JC, Ying GS, Brucker AJ, Dunaief JL: Foveolar choroidal circulation and choroidal neovascularization in age-related macular degeneration. Invest Ophthalmol Vis Sci 2008; 49: 358-363.
40. Grunwald JE, Hariprasad SM, DuPont J, Maguire MG, Fine SL, Brucker AJ, Maguire AM, Ho AC: Foveolar choroidal blood flow in age-related macular degeneration. Invest Ophthalmol Vis Sci 1998; 39: 385-390. (Pubitemid 28093877)
41. Grunwald JE, Metelitsina TI, DuPont JC, Ying GS, Maguire MG: Reduced foveolar choroidal blood flow in eyes with increasing AMD severity. Invest Ophthalmol Vis Sci 2005; 46: 1033-1038. (Pubitemid 41321042)
42. Chen SJ, Cheng CY, Lee AF, Lee FL, Chou JC, Hsu WM, Liu JH: Pulsatile ocular blood flow in asymmetric exudative age related macular degeneration. Br J Ophthalmol 2001; 85: 1411-1415. (Pubitemid 34032903)
43. Bird AC: Choroidal neovascularisation in age-related macular disease. Br J Ophthalmol 1993; 77: 614-615. (Pubitemid 23298379)
44. Lahiri S, Roy A, Baby SM, Hoshi T, Semenza GL, Prabhakar NR: Oxygen sensing in the body. Prog Biophys Mol Biol 2006; 91: 249-286.
45. Weir EK, Lopez-Barneo J, Buckler KJ, Archer SL: Acute oxygen-sensing mechanisms. N Engl J Med 2005; 353: 2042-2055.
46. Lopez-Barneo J, Ortega-Saenz P, Molina A, Franco-Obregon A, Urena J, Castellano A: Oxygen sensing by ion channels. Kidney Int 1997; 51: 454-461. (Pubitemid 27088158)
47. Standen NB, Quayle JM, Davies NW, Brayden JE, Huang Y, Nelson MT: Hyperpolarizing vasodilators activate ATP-sensitive K + channels in arterial smooth muscle. Science 1989; 245: 177-180. (Pubitemid 19193933)
48. Daut J, Maier-Rudolph W, von BN, Mehrke G, Gunther K, Goedel-Meinen L: Hypoxic dilation of coronary arteries is mediated by ATP-sensitive potassium channels. Science 1990; 247: 1341-1344.
49. Ohya Y, Sperelakis N: Fast Na + and slow Ca 2+ channels in single uterine muscle cells from pregnant rats. Am J Physiol 1989; 257:C408-C412.
50. Okashiro T, Tokuno H, Fukumitsu T, Hayashi H, Tomita T: Effects of intracellular ATP on calcium current in freshly dispersed single cells of guinea-pig portal vein. Exp Physiol 1992; 77: 719-731.
51. Rekalov V, Juranek I, Malekova L, Bauer V: Hypoxia-induced inhibition of calcium channels in guinea-pig taenia caeci smooth muscle cells. J Physiol 1997; 505: 107-119. (Pubitemid 27504285)
52. Nagaoka T, Sakamoto T, Mori F, Sato E, Yoshida A: The effect of nitric oxide on retinal blood flow during hypoxia in cats. Invest Ophthalmol Vis Sci 2002; 43: 3037-3044. (Pubitemid 34977057)
53. Maenhaut N, Boussery K, Delaey C, Van de Voorde J: Adenosine enhances the relaxing influence of retinal tissue. Exp Eye Res 2009; 88: 71-78.
54. Bruick RK, McKnight SL: A conserved family of prolyl-4-hydroxylases that modify HIF. Science 2001; 294: 1337-1340. (Pubitemid 33063099)
55. Kibel A, Iliopoulos O, DeCaprio JA, Kaelin WG Jr: Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C. Science 1995; 269: 1444-1446.
56. Pause A, Lee S, Worrell RA, Chen DY, Burgess WH, Linehan WM, Klausner RD: The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins. Proc Natl Acad Sci USA 1997; 94: 2156-2161. (Pubitemid 27136844)
57. Iwai K, Yamanaka K, Kamura T, Minato N, Conaway RC, Conaway JW, Klausner RD, Pause A: Identification of the von Hippel- Lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. Proc Natl Acad Sci USA 1999; 96: 12436-12441. (Pubitemid 29513520)
58. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ: The tumour suppressor protein VHL targets hypoxia- inducible factors for oxygen-dependent proteolysis. Nature 1999; 399: 271-275. (Pubitemid 29246458)
59. IVan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS, Kaelin WG Jr: HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O 2 sensing. Science 2001; 292: 464-468. (Pubitemid 32335941)
60. Mahon PC, Hirota K, Semenza GL: FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev 2001; 15: 2675-2686. (Pubitemid 32988878)
61. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL: Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996; 16: 4604-4613. (Pubitemid 26272112)
62. Melillo G, Musso T, Sica A, Taylor LS, Cox GW, Varesio L: A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J Exp Med 1995; 182: 1683-1693.
63. Wang GL, Semenza GL: Molecular basis of hypoxia-induced erythropoietin expression. Curr Opin Hematol 1996; 3: 156-162. (Pubitemid 26178055)
64. Hu J, Discher DJ, Bishopric NH, Webster KA: Hypoxia regulates expression of the endothelin- 1 gene through a proximal hypoxia- inducible factor-1 binding site on the antisense strand. Biochem Biophys Res Commun 1998; 245: 894-899. (Pubitemid 28414014)
65. Sharp FR, Bernaudin M: HIF1 and oxygen sensing in the brain. Nat Rev Neurosci 2004; 5: 437-448. (Pubitemid 38715511)
66. Bergeron M, Yu AY, Solway KE, Semenza GL, Sharp FR: Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain. Eur J Neurosci 1999; 11: 4159-4170. (Pubitemid 30009246)
67. Olson N, Van Der Vliet A: Interactions between nitric oxide and hypoxia-inducible factor signaling pathways in inflammatory disease. Nitric Oxide 2011; 25: 125-137.
68. Tian H, McKnight SL, Russell DW: Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev 1997; 11: 72-82. (Pubitemid 27043825)
69. Lofstedt T, Fredlund E, Holmquist-Mengelbier L, Pietras A, Ovenberger M, Poellinger L, Pahlman S: Hypoxia inducible factor-2alpha in cancer. Cell Cycle 2007; 6: 919-926.
70. Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, Wenger RH, Gassmann M, Gearhart JD, Lawler AM, Yu AY, Semenza GL: Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 1998; 12: 149-162. (Pubitemid 28060446)
71. Hu LH, Yang JH, Zhang DT, Zhang S, Wang L, Cai PC, Zheng JF, Huang JS: The TKTL1 gene influences total transketolase activity and cell proliferation in human colon cancer LoVo cells. Anticancer Drugs 2007; 18: 427-433. (Pubitemid 46712406)
72. Hu CJ, Wang LY, Chodosh LA, Keith B, Simon MC: Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF- 2alpha in hypoxic gene regulation. Mol Cell Biol 2003; 23: 9361-9374. (Pubitemid 37499822)
73. Wang V, Davis DA, Haque M, Huang LE, Yarchoan R: Differential gene up-regulation by hypoxia-inducible factor-1alpha and hypoxia- inducible factor-2alpha in HEK293T cells. Cancer Res 2005; 65: 3299-3306. (Pubitemid 40524614)
74. Grabmaier K, de Weijert MC, Verhaegh GW, Schalken JA, Oosterwijk E: Strict regulation of CAIX(G250/MN) by HIF-1alpha in clear cell renal cell carcinoma. Oncogene 2004; 23: 5624-5631. (Pubitemid 39093040)
75. Raval RR, Lau KW, Tran MG, Sowter HM, Mandriota SJ, Li JL, Pugh CW, Maxwell PH, Harris AL, Ratcliffe PJ: Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Mol Cell Biol 2005; 25: 5675-5686. (Pubitemid 40853601)
76. Gunaratnam L, Morley M, Franovic A, de Paulsen N, Mekhail K, Parolin DA, Nakamura E, Lorimer IA, Lee S: Hypoxia inducible factor activates the transforming growth factor- alpha/epidermal growth factor receptor growth stimulatory pathway in VHL(-/-) renal cell carcinoma cells. J Biol Chem 2003; 278: 44966-44974. (Pubitemid 37377256)
77. Makino Y, Cao R, Svensson K, Bertilsson G, Asman M, Tanaka H, Cao Y, Berkenstam A, Poellinger L: Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature 2001; 414: 550-554. (Pubitemid 33131538)
78. Kurihara T, Kubota Y, Ozawa Y, Takubo K, Noda K, Simon MC, Johnson RS, Suematsu M, Tsubota K, Ishida S, Goda N, Suda T, Okano H: von Hippel-Lindau protein regulates transition from the fetal to the adult circulatory system in retina. Development 2010; 137: 1563-1571.
79. Ozaki H, Yu AY, Della N, Ozaki K, Luna JD, Yamada H, Hackett SF, Okamoto N, Zack DJ, Semenza GL, Campochiaro PA: Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression. Invest Ophthalmol Vis Sci 1999; 40: 182-189. (Pubitemid 29029587)
80. Caprara C, Thiersch M, Lange C, Joly S, Samardzija M, Grimm C: HIF1A is essential for the development of the intermediate plexus of the retinal vasculature. Invest Ophthalmol Vis Sci 2011; 52: 2109-2117.
81. Lange C, Caprara C, Tanimoto N, Beck S, Huber G, Samardzija M, Seeliger M, Grimm C: Retina-specific activation of a sustained hypoxia-like response leads to severe retinal degeneration and loss of vision. Neurobiol Dis 2011; 41: 119-130.
82. Hughes JM, Groot AJ, Van Der Groep P, Sersansie R, Vooijs M, Van Diest PJ, Van Noorden CJ, Schlingemann RO, Klaassen I: Active HIF-1 in the normal human retina. J Histochem Cytochem 2010; 58: 247-254.
83. Kaur C, Sivakumar V, Foulds WS, Luu CD, Ling EA: Cellular and vascular changes in the retina of neonatal rats after an acute exposure to hypoxia. Invest Ophthalmol Vis Sci 2009; 50: 5364-5374.
84. Mowat FM, Luhmann UF, Smith AJ, Lange C, Duran Y, Harten S, Shukla D, Maxwell PH, Ali RR, Bainbridge JW: HIF-1alpha and HIF-2alpha are differentially activated in distinct cell populations in retinal ischaemia. PLoS ONE 2010; 5:e11103.
85. Crosson LA, Kroes RA, Moskal JR, Linsenmeier RA: Gene expression patterns in hypoxic and post-hypoxic adult rat retina with special reference to the NMDA receptor and its interactome. Mol Vis 2009; 15: 296-311.
86. Lin M, Chen Y, Jin J, Hu Y, Zhou KK, Zhu M, Le YZ, Ge J, Johnson RS, Ma JX: Ischaemiainduced retinal neovascularisation and diabetic retinopathy in mice with conditional knockout of hypoxia-inducible factor-1 in retinal Muller cells. Diabetologia 2011; 54: 1554-1566.
87. Weidemann A, Krohne TU, Aguilar E, Kurihara T, Takeda N, Dorrell MI, Simon MC, Haase VH, Friedlander M, Johnson RS: Astrocyte hypoxic response is essential for pathological but not developmental angiogenesis of the retina. Glia 2010; 58: 1177-1185.
88. Li C, Xu Y, Jiang D, Hong W, Guo X, Wang P, Li W: The expression of HIF-1 in the early diabetic NOD mice. Yan Ke Xue Bao 2006; 22: 107-111.
89. Wright WS, McElhatten RM, Messina JE, Harris NR: Hypoxia and the expression of HIF-1alpha and HIF-2alpha in the retina of streptozotocin-injected mice and rats. Exp Eye Res 2010; 90: 405-412.
90. Wang X, Wang G, Wang Y: Intravitreous vascular endothelial growth factor and hypoxia- inducible factor 1a in patients with proliferative diabetic retinopathy. Am J Ophthalmol 2009; 148: 883-889.
91. Inomata Y, Hirata A, Takahashi E, Kawaji T, Fukushima M, Tanihara H: Elevated erythropoietin in vitreous with ischemic retinal diseases. Neuroreport 2004; 15: 877-879. (Pubitemid 38453478)
92. Matsunaga N, Chikaraishi Y, Izuta H, Ogata N, Shimazawa M, Matsumura M, Hara H: Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy. Ophthalmology 2008; 115: 1916-1922.
93. Kuiper EJ, Van Nieuwenhoven FA, de Smet MD, Van Meurs JC, Tanck MW, Oliver N, Klaassen I, Van Noorden CJ, Goldschmeding R, Schlingemann RO: The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy. PLoS ONE 2008; 3:e2675.
94. bu El-Asrar AM, Missotten L, Geboes K: Expression of hypoxia-inducible factor-1alpha and the protein products of its target genes in diabetic fibrovascular epiretinal membranes. Br J Ophthalmol 2007; 91: 822-826. (Pubitemid 46846660)
95. Lim JI, Spee C, Hinton DR: A comparison of hypoxia-inducible factor-alpha in surgically excised neovascular membranes of patients with diabetes compared with idiopathic epiretinal membranes in nondiabetic patients. Retina 2010; 30: 1472-1478.
96. Dehne N, Brune B: HIF-1 in the inflammatory microenvironment. Exp Cell Res 2009; 315: 1791-1797.
97. Noma H, Funatsu H, Mimura T, Eguchi S, Shimada K, Hori S: Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in macular edema with central retinal vein occlusion. Curr Eye Res 2011; 36: 256-263.
98. Stahl A, Buchwald A, Martin G, Junker B, Chen J, Hansen LL, Agostini HT, Smith LE, Feltgen N: Vitreal levels of erythropoietin are increased in patients with retinal vein occlusion and correlate with vitreal VEGF and the extent of macular edema. Retina 2010; 30: 1524-1529.
99. Inoue Y, Yanagi Y, Matsuura K, Takahashi H, Tamaki Y, Araie M: Expression of hypoxia- inducible factor 1alpha and 2alpha in choroidal neovascular membranes associated with age-related macular degeneration. Br J Ophthalmol 2007; 91: 1720-1721. (Pubitemid 350207415)
100. Sheridan CM, Pate S, Hiscott P, Wong D, Pattwell DM, Kent D: Expression of hypoxia- inducible factor-1alpha and -2alpha in human choroidal neovascular membranes. Graefes Arch Clin Exp Ophthalmol 2009; 247: 1361-1367.
101. Lange CA, Mowat FM, Luhmann UFO, Smith AJ, Maxwell PH, Ali RR, Bainbridge JW: Von Hippel-Lindau expression in the retinal pigment epithelium is essential for normal eye development and vascular homeostasis. ARVO abstract 2010; 5973/A194.
102. Frayser R, Gray GW, Houston CS: Control of the retinal circulation at altitude. J Appl Physiol 1974; 37: 302-304.
103. Papst N, Demant E, Niemeyer G: Changes in pO 2 induce retinal autoregulation in vitro. Graefes Arch Clin Exp Ophthalmol 1982; 219: 6-10. (Pubitemid 12082239)
104. Brinchmann-Hansen O, Myhre K, Sandvik L: Retinal vessel responses to exercise and hypoxia before and after high altitude acclimatisation. Eye (Lond) 1989; 3: 768-776. (Pubitemid 20074142)
105. Rennie D, Morrissey J: Retinal changes in Himalayan climbers. Arch Ophthalmol 1975; 93: 395-400.
106. Kergoat H, Marinier JA, Lovasik JV: Effects of transient mild systemic hypoxia on the pulsatile choroidal blood flow in healthy young human adults. Curr Eye Res 2005; 30: 465-470. (Pubitemid 40961111)
107. Bosch MM, Merz TM, Barthelmes D, Petrig BL, Truffer F, Bloch KE, Turk A, Maggiorini M, Hess T, Schoch OD, Hefti U, Sutter FK, Pichler J, Huber A, Landau K: New insights into ocular blood flow at very high altitudes. J Appl Physiol 2009; 106: 454-460.
108. Michaelson IC, Herz N, Lewkowitz E, Kertesz D: Effect of increased oxygen on the development of the retinal vessels; an experimental study. Br J Ophthalmol 1954; 38: 577-587.
109. Wise GN: Retinal neovascularization. Trans Am Ophthalmol Soc 1956; 54: 729-826.
110. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994; 331: 1480-1487. (Pubitemid 24356306)
111. Holmes DI, Zachary I: The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease. Genome Biol 2005; 6: 209.
112. De Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT: The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992; 255: 989-991.
113. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NP, Risau W, Ullrich A: High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993; 72: 835-846. (Pubitemid 23110226)
114. Miller JW, Adamis AP, Shima DT, D'Amore PA, Moulton RS, O'Reilly MS, Folkman J, Dvorak HF, Brown LF, Berse B: Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol 1994; 145: 574-584. (Pubitemid 24285965)
115. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J: Vascular-specific growth factors and blood vessel formation. Nature 2000; 407: 242-248.
116. Marneros AG, Fan J, Yokoyama Y, Gerber HP, Ferrara N, Crouch RK, Olsen BR: Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function. Am J Pathol 2005; 167: 1451-1459. (Pubitemid 41541430)
117. Zhang P, Wang Y, Hui Y, Hu D, Wang H, Zhou J, Du H: Inhibition of VEGF expression by targeting HIF-1 alpha with small interference RNA in human RPE cells. Ophthalmologica 2007; 221: 411-417. (Pubitemid 47608868)
118. Liu XL, Li YJ, Liu YZ, Ge J: Effects of human retinal glial cells under hypoxic conditions on circulating endothelial progenitor cells. Zhonghua Yan Ke Za Zhi 2006; 42: 1089-1094.
119. Cormier-Regard S, Nguyen SV, Claycomb WC: Adrenomedullin gene expression is developmentally regulated and induced by hypoxia in rat ventricular cardiac myocytes. J Biol Chem 1998; 273: 17787-17792. (Pubitemid 28355122)
120. Kietzmann T, Roth U, Jungermann K: Induction of the plasminogen activator inhibitor- 1 gene expression by mild hypoxia via a hypoxia response element binding the hypoxia- inducible factor-1 in rat hepatocytes. Blood 1999; 94: 4177-4185.
121. Fuchshofer R, Yu AL, Teng HH, Strauss R, Kampik A, Welge-Lussen U: Hypoxia/reoxygenation induces CTGF and PAI-1 in cultured human retinal pigment epithelium cells. Exp Eye Res 2009; 88: 889-899.
122. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T: Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993; 192: 553-560. (Pubitemid 23227359)
123. Ribatti D, Nico B, Spinazzi R, Vacca A, Nussdorfer GG: The role of adrenomedullin in angiogenesis. Peptides 2005; 26: 1670-1675. (Pubitemid 41169764)
124. Udono T, Takahashi K, Nakayama M, Murakami O, Durlu YK, Tamai M, Shibahara S: Adrenomedullin in cultured human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 2000; 41: 1962-1970. (Pubitemid 30354374)
125. Zhu Y, Zhang L, Gidday JM: Deferroxamine preconditioning promotes long-lasting retinal ischemic tolerance. J Ocul Pharmacol Ther 2008; 24: 527-535.
126. Perbal B: CCN proteins: multifunctional signalling regulators. Lancet 2004; 363: 62-64. (Pubitemid 38076928)
127. Van Meurs JC, Bolt BJ, Mertens DA, Peperkamp E, De WP: Rubeosis of the iris in proliferative vitreoretinopathy. Retina 1996; 16: 292-295. (Pubitemid 26282710)
128. Schachat AP, Oyakawa RT, Michels RG, Rice TA: Complications of vitreous surgery for diabetic retinopathy. 2. Postoperative complications. Ophthalmology 1983; 90: 522-530.
129. Shui YB, Holekamp NM, Kramer BC, Crowley JR, Wilkins MA, Chu F, Malone PE, Mangers SJ, Hou JH, Siegfried CJ, Beebe DC: The gel state of the vitreous and ascorbate- dependent oxygen consumption: relationship to the etiology of nuclear cataracts. Arch Ophthalmol 2009; 127: 475-482.
130. Stefansson E: Physiology of vitreous surgery. Graefes Arch Clin Exp Ophthalmol 2009; 247: 147-163.
131. Arden GB, Wolf JE, Tsang Y: Does dark adaptation exacerbate diabetic retinopathy? Evidence and a linking hypothesis. Vision Res 1998; 38: 1723-1729. (Pubitemid 28302165)
132. Arden GB, Gunduz MK, Kurtenbach A, Volker M, Zrenner E, Gunduz SB, Kamis U, Ozturk BT, Okudan S: A preliminary trial to determine whether prevention of dark adaptation affects the course of early diabetic retinopathy. Eye (Lond) 2010; 24: 1149-1155.
133. Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ: Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 2011; 364: 1897-1908.
134. Avery RL, Pearlman J, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ, Wendel R, Patel A: Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 2006; 113: 1695-1615.
135. Tolentino M: Systemic and ocular safety of intravitreal anti-VEGF therapies for ocular neovascular disease. Surv Ophthalmol 2011; 56: 95-113.
136. Sears JE, Hoppe G, Ebrahem Q, Anand-Apte B: Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy. Proc Natl Acad Sci USA 2008; 105: 19898-19903.
137. Ren H, Liu NY, Song XF, Ma YS, Zhai XY: A novel specific application of pyruvate protects the mouse retina against white light damage: differential stabilization of HIF-1α and HIF-2α . Invest Ophthalmol Vis Sci 2011; 52: 3112-3118.
138. Yoshida T, Zhang H, Iwase T, Shen J, Semenza GL, Campochiaro PA: Digoxin inhibits retinal ischemia-induced HIF-1alpha expression and ocular neovascularization. FASEB J 2010; 24: 1759-1767.
139. Stroka DM, Burkhardt T, Desbaillets I, Wenger RH, Neil DA, Bauer C, Gassmann M, Candinas D: HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J 2001; 15: 2445-2453. (Pubitemid 33063172)
140. Wiesener MS, Jurgensen JS, Rosenberger C, Scholze CK, Horstrup JH, Warnecke C, Mandriota S, Bechmann I, Frei UA, Pugh CW, Ratcliffe PJ, Bachmann S, Maxwell PH, Eckardt KU: Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs. FASEB J 2003; 17: 271-273.
141. Zhang C, Wang YS, Wu H, Zhang ZX, Cai Y, Hou HY, Zhao W, Yang XM, Ma JX: Inhibitory efficacy of hypoxia-inducible factor 1alpha short hairpin RNA plasmid DNA-loaded poly ( D , L -lactide-co-glycolide) nanoparticles on choroidal neovascularization in a laser-induced rat model. Gene Ther 2010; 17: 338-351.
142. Akiyama H, Tanaka T, Itakura H, Kanai H, Maeno T, Doi H, Yamazaki M, Takahashi K, Kimura Y, Kishi S, Kurabayashi M: Inhibition of ocular angiogenesis by an adenovirus carrying the human von Hippel-Lindau tumor-suppressor gene in vivo. Invest Ophthalmol Vis Sci 2004; 45: 1289-1296. (Pubitemid 38859301)
143. Yeo EJ, Chun YS, Cho YS, Kim J, Lee JC, Kim MS, Park JW: YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1. J Natl Cancer Inst 2003; 95: 516-525. (Pubitemid 36511622)
144. Kaur C, Sivakumar V, Foulds WS: Early response of neurons and glial cells to hypoxia in the retina. Invest Ophthalmol Vis Sci 2006; 47: 1126-1141.
145. Thiersch M, Raffelsberger W, Frigg R, Samardzija M, Wenzel A, Poch O, Grimm C: Analysis of the retinal gene expression profile after hypoxic preconditioning identifies candidate genes for neuroprotection. BMC Genomics 2008; 9: 73.
146. Kaur C, Sivakumar V, Foulds WS, Luu CD, Ling EA: Cellular and vascular changes in the retina of neonatal rats after an acute exposure to hypoxia. Invest Ophthalmol Vis Sci 2009; 50: 5364-5374.
147. Sivakumar V, Zhang Y, Ling EA, Foulds WS, Kaur C: Insulin-like growth factors, angiopoietin-2, and pigment epitheliumderived growth factor in the hypoxic retina. J Neurosci Res 2008; 86: 702-711. (Pubitemid 351204485)
148. Sivakumar V, Foulds WS, Luu CD, Ling EA, Kaur C: Retinal ganglion cell death is induced by microglia derived pro-inflammatory cytokines in the hypoxic neonatal retina. J Pathol 2011; 224: 245-260.
149. Palmer LA, Semenza GL, Stoler MH, Johns RA: Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1. Am J Physiol 1998; 274:L212-L219.
150. Eckhart AD, Yang N, Xin X, Faber JE: Characterization of the alpha1B-adrenergic receptor gene promoter region and hypoxia regulatory elements in vascular smooth muscle. Proc Natl Acad Sci USA 1997; 94: 9487-9492.
151. Hu J, Discher DJ, Bishopric NH, Webster KA: Hypoxia regulates expression of the endothelin-1 gene through a proximal hypoxia- inducible factor-1 binding site on the antisense strand. Biochem Biophys Res Commun 1998; 245: 894-899. (Pubitemid 28414014)
152. Millhorn DE, Raymond R, Conforti L, Zhu W, Beitner-Johnson D, Filisko T, Genter MB, Kobayashi S, Peng M: Regulation of gene expression for tyrosine hydroxylase in oxygen sensitive cells by hypoxia. Kidney Int 1997; 51: 527-535. (Pubitemid 27088170)
153. Chun YS, Hyun JY, Kwak YG, Kim IS, Kim CH, Choi E, Kim MS, Park JW: Hypoxic activation of the atrial natriuretic peptide gene promoter through direct and indirect actions of hypoxia-inducible factor-1. Biochem J 2003; 370: 149-157. (Pubitemid 36259427)
154. Gerber HP, Condorelli F, Park J, Ferrara N: Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J Biol Chem 1997; 272: 23659-23667. (Pubitemid 27410939)
155. Ronkainen VP, Ronkainen JJ, Hanninen SL, Leskinen H, Ruas JL, Pereira T, Poellinger L, Vuolteenaho O, Tavi P: Hypoxia inducible factor regulates the cardiac expression and secretion of apelin. FASEB J 2007; 21: 1821-1830. (Pubitemid 46855628)
156. Higgins DF, Biju MP, Akai Y, Wutz A, Johnson RS, Haase VH: Hypoxic induction of Ctgf is directly mediated by Hif-1. Am J Physiol Renal Physiol 2004; 287:F1223-F1232. (Pubitemid 39507231)
157. Rolfs A, Kvietikova I, Gassmann M, Wenger RH: Oxygen-regulated transferrin expression is mediated by hypoxia-inducible factor- 1. J Biol Chem 1997; 272: 20055-20062. (Pubitemid 27340110)
158. Tacchini L, Bianchi L, Bernelli-Zazzera A, Cairo G: Transferrin receptor induction by hypoxia. HIF-1-mediated transcriptional activation and cell-specific post-transcriptional regulation. J Biol Chem 1999; 274: 24142-24146.
159. Mukhopadhyay CK, Mazumder B, Fox PL: Role of hypoxia-inducible factor-1 in transcriptional activation of ceruloplasmin by iron deficiency. J Biol Chem 2000; 275: 21048-21054. (Pubitemid 30481794)
160. Wang D, Wang LH, Zhao Y, Lu YP, Zhu L: Hypoxia regulates the ferrous iron uptake and reactive oxygen species level via divalent metal transporter 1 (DMT1) Exon1B by hypoxia-inducible factor-1. IUBMB Life 2010; 62: 629-636.
161. Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Koch CJ, Ratcliffe P, Moons L, Jain RK, Collen D, Keshert E: Role of HIF-1alpha in hypoxia- mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998; 394: 485-490. (Pubitemid 28373960)
162. Feldser D, Agani F, Iyer NV, Pak B, Ferreira G, Semenza GL: Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. Cancer Res 1999; 59: 3915-3918. (Pubitemid 29393552)
163. Tazuke SI, Mazure NM, Sugawara J, Carland G, Faessen GH, Suen LF, Irwin JC, Powell DR, Giaccia AJ, Giudice LC: Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: a possible model for IGFBP-1 expression in fetal hypoxia. Proc Natl Acad Sci USA 1998; 95: 10188-10193.
164. Sanchez-Elsner T, Botella LM, Velasco B, Langa C, Bernabeu C: Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-beta pathways. J Biol Chem 2002; 277: 43799-43808. (Pubitemid 36157800)
165. Wagner KD, Wagner N, Wellmann S, Schley G, Bondke A, Theres H, Scholz H: Oxygen-regulated expression of the Wilms' tumor suppressor Wt1 involves hypoxiainducible factor-1 (HIF-1). FASEB J 2003; 17: 1364-1366.
166. Mazure NM, Chauvet C, Bois-Joyeux B, Bernard MA, Nacer-Cherif H, Danan JL: Repression of alpha-fetoprotein gene expression under hypoxic conditions in human hepatoma cells: characterization of a negative hypoxia response element that mediates opposite effects of hypoxia inducible factor-1 and c-Myc. Cancer Res 2002; 62: 1158-1165. (Pubitemid 34160303)
167. Nikitenko LL, Smith DM, Bicknell R, Rees MC: Transcriptional regulation of the CRLR gene in human microvascular endothelial cells by hypoxia. FASEB J 2003; 17: 1499-1501.
168. Bruick RK: Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc Natl Acad Sci USA 2000; 97: 9082-9087. (Pubitemid 30626677)
169. An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV, Neckers LM: Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature 1998; 392: 405-408.
170. Staller P, Sulitkova J, Lisztwan J, Moch H, Oakeley EJ, Krek W: Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature 2003; 425: 307-311. (Pubitemid 37158407)
171. Takahashi Y, Takahashi S, Shiga Y, Yoshimi T, Miura T: Hypoxic induction of prolyl 4-hydroxylase alpha (I) in cultured cells. J Biol Chem 2000; 275: 14139-14146. (Pubitemid 30339690)
172. Semenza GL, Roth PH, Fang HM, Wang GL: Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 1994; 269: 23757-23763. (Pubitemid 24293585)
173. Lofstedt T, Fredlund E, Noguera R, Navarro S, Holmquist-Mengelbier L, Beckman S, Pahlman S, Axelson H: HIF-1alpha induces MXI1 by alternate promoter usage in human neuroblastoma cells. Exp Cell Res 2009; 315: 1924-1936.
174. Kim JW, Tchernyshyov I, Semenza GL, Dang CV: HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 2006; 3: 177-185.
175. Ullah MS, Davies AJ, Halestrap AP: The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism. J Biol Chem 2006; 281: 9030-9037. (Pubitemid 43864615)
176. Fukuda R, Zhang H, Kim JW, Shimoda L, Dang CV, Semenza GL: HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell 2007; 129: 111-122. (Pubitemid 46507584)
177. Graven KK, Yu Q, Pan D, Roncarati JS, Farber HW: Identification of an oxygen responsive enhancer element in the glyceraldehyde- 3-phosphate dehydrogenase gene. Biochim Biophys Acta 1999; 1447: 208-218. (Pubitemid 29494992)
178. Minchenko O, Opentanova I, Caro J: Hypoxic regulation of the 6-phosphofructo-2- kinase/fructose-2,6-bisphosphatase gene family (PFKFB-1-4) expression in vivo. FEBS Lett 2003; 554: 264-270. (Pubitemid 37412497)
179. Schaffer L, Scheid A, Spielmann P, Breymann C, Zimmermann R, Meuli M, Gassmann M, Marti HH, Wenger RH: Oxygen- regulated expression of TGF-beta 3, a growth factor involved in trophoblast differentiation. Placenta 2003; 24: 941-950. (Pubitemid 37321809)
180. Lee PJ, Jiang BH, Chin BY, Iyer NV, Alam J, Semenza GL, Choi AM: Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J Biol Chem 1997; 272: 5375-5381. (Pubitemid 27102353)
181. O'Rourke JF, Pugh CW, Bartlett SM, Ratcliffe PJ: Identification of hypoxically inducible mRNAs in HeLa cells using differential- display PCR. Role of hypoxia-inducible factor-1. Eur J Biochem 1996; 241: 403-410. (Pubitemid 26356826)
182. Kaluz S, Kaluzova M, Chrastina A, Olive PL, Pastorekova S, Pastorek J, Lerman MI, Stanbridge EJ: Lowered oxygen tension induces expression of the hypoxia marker MN/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1 alpha stabilization: a role for phosphatidylinositol 3'-kinase. Cancer Res 2002; 62: 4469-4477. (Pubitemid 34827310)
183. Grosfeld A, Andre J, Hauguel-De MS, Berra E, Pouyssegur J, Guerre-Millo M: Hypoxiainducible factor 1 transactivates the human leptin gene promoter. J Biol Chem 2002; 277: 42953-42957. (Pubitemid 35285673)
184. Hackenbeck T, Huber R, Schietke R, Knaup KX, Monti J, Wu X, Klanke B, Frey B, Gaipl U, Wullich B, Ferbus D, Goubin G, Warnecke C, Eckardt KU, Wiesener MS: The GTPase RAB20 is a HIF target with mitochondrial localization mediating apoptosis in hypoxia. Biochim Biophys Acta 2011; 1813: 1-13.